glp-1 patch reviews Gentle Patches Review​ GLP-1 Patches': Do the Products

Falk, S

PMID: 22836857

Notably, there is an FDA proposal to exclude certain active ingredients in Novo's products from the mass compounding list

Since being overweight or obese greatly increases the likelihood of developing colorectal cancer (CRC) [148]

This is supported by recent studies from US and German adults with T2D, which reported that the use of GLP-1RAs versus insulin resulted in lower emergency room visits and inpatient admissions but higher drug acquisition costs after treatment initiation [49, 50]

Efficacy and safety of once-weekly dulaglutide versus insulin glargine in patients with type 2 diabetes on metformin and glimepiride (AWARD-2)